NCT06163768 Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients

Eligibility & Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1 participants in total. It began in 2023-12-31 with a primary completion date of 2026-10-31.

Brief Summary

Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)

Eligibility Criteria

Inclusion Criteria: * Control group The researcher collected samples from healthy people over 18 years old who came for a health check and were concluded to have good health at the Health Examination Department of University of Medicine and Pharmacy Hospital, Ho Chi Minh City. Not falling within the exclusion criteria and agreeing to participate in the study were included in the study. * Researchers -All patients diagnosed with Acute coronary syndrome who were over 18 years old, met the inclusion criteria and did not have exclusion criteria, and agreed to participate in the study were included in the study. Exclusion Criteria: * Control group * Patients \< 18 years old. * History of heart disease or stroke * Exclude diabetic subjects * Exclude subjects at high risk of insulin resistance * Researchers * Have diabetes or have previously been diagnosed with diabetes. * Patients \< 18 years old. * The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility. * The patient died before reaching the hospital. * Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.

Contact & Investigator

Frequently Asked Questions

Related Trials